A
Acrivon Therapeutics (ACRV)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acrivon Therapeutics (ACRV)
Acrivon Therapeutics, Inc. is a United States-based is a clinical-stage oncology therapeutics company. The Company provides technologies driving precision-based medicine. It leverages its phosphoproteomics technology called Acrivon Precision Predicti... Read more
- USD1.24
- USD1.25
- USD1.16
- USD10.16
- -11.50%
- --
- 1.43M
- 44M
- 1.17
- -85.30%
Stock News
4 hours ago
Rivian: Near-Term Deliveries Cut Has No Bearing On R2's Future
SeekingAlpha
4 hours ago
Rates Spark: Market Discount Shifts To Un-Discounting Some Recession Risks
SeekingAlpha
4 hours ago
Uber: Accelerates AV Ambitions As Growth Shows Signs Of Stalling
SeekingAlpha
4 hours ago
The Next Frontier In Portfolio Design: Keeping Equities While Adding Gold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
